Clinical Research Directory
Browse clinical research sites, groups, and studies.
Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion
Sponsor: Xin Cai
Summary
Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)
Official title: A Prospective Phase II Clinical Study of Carbon Ion Re-irradiation in Unresectable Locally Recurrent Rectal Cancer
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
31
Start Date
2023-05-01
Completion Date
2026-12-31
Last Updated
2023-04-11
Healthy Volunteers
No
Conditions
Interventions
Carbon ion radiation therapy DT: 74Gy/20 fractions
patients with unresectable local recurrent rectal cancer will be treated with carbon ion radiation therapy as re-irradiation
Locations (1)
Shanghai Proton and Heavy ion center
Shanghai, Pudong, China